Deborah H Telman - Net Worth and Insider Trading

Deborah H Telman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah H Telman owns 3 companies in total, including AtriCure Inc (ATRC) , Organon & Co (OGN) , and Gilead Sciences Inc (GILD) .

Click here to see the complete history of Deborah H Telman’s form 4 insider trades.

Insider Ownership Summary of Deborah H Telman

Ticker	Comapny	Transaction Date	Type of Owner
ATRC	AtriCure Inc	2021-06-15	director
OGN	Organon & Co	2021-06-02	General Counsel
GILD	Gilead Sciences Inc	2022-08-01	EVP & Corporate Affairs & GC

Deborah H Telman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah H Telman Ownership Network

Ownership Network List of Deborah H Telman

No Data

Ownership Network Relation of Deborah H Telman

Deborah H Telman Owned Company Details

What does AtriCure Inc do?

Who are the key executives at AtriCure Inc?

Deborah H Telman is the director of AtriCure Inc. Other key executives at AtriCure Inc include SVP & Mktg & Business Develop Justin J Noznesky , Chief Legal Officer Karl S. Dahlquist , and Chief Scientific Officer Vinayak Doraiswamy .

AtriCure Inc (ATRC) Insider Trades Summary

Over the past 18 months, Deborah H Telman made no insider transaction in AtriCure Inc (ATRC). Other recent insider transactions involving AtriCure Inc (ATRC) include a net sale of 20,620 shares made by Karl S. Dahlquist , a net sale of 3,000 shares made by Justin J Noznesky , and a net sale of 4,313 shares made by Maggie Yuen .

In summary, during the past 3 months, insiders sold 13,116 shares of AtriCure Inc (ATRC) in total and bought 0 shares, with a net sale of 13,116 shares. During the past 18 months, 28,646 shares of AtriCure Inc (ATRC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,646 shares.

AtriCure Inc (ATRC)'s detailed insider trading history can be found in Insider Trading Tracker table.

AtriCure Inc Insider Transactions

No Available Data

What does Organon & Co do?

Who are the key executives at Organon & Co?

Deborah H Telman is the General Counsel of Organon & Co. Other key executives at Organon & Co include Gen. Counsel & Corp. Secy. Kirke Weaver , Chief Information Officer Rachel A Stahler , and Head of Research & Development Sandra Milligan .

Organon & Co (OGN) Insider Trades Summary

Over the past 18 months, Deborah H Telman made no insider transaction in Organon & Co (OGN). Other recent insider transactions involving Organon & Co (OGN) include a net purchase of 2,720 shares made by Kirke Weaver ,

In summary, during the past 3 months, insiders sold 0 shares of Organon & Co (OGN) in total and bought 2,720 shares, with a net purchase of 2,720 shares. During the past 18 months, 0 shares of Organon & Co (OGN) were sold and 2,720 shares were bought by its insiders, resulting in a net purchase of 2,720 shares.

Organon & Co (OGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Organon & Co Insider Transactions

No Available Data

What does Gilead Sciences Inc do?

Who are the key executives at Gilead Sciences Inc?

Deborah H Telman is the EVP & Corporate Affairs & GC of Gilead Sciences Inc. Other key executives at Gilead Sciences Inc include Chief Medical Officer Merdad Parsey , EVP & Chief Financial Officer Andrew D Dickinson , and Chief Commercial Officer Johanna Mercier .

Gilead Sciences Inc (GILD) Insider Trades Summary

Over the past 18 months, Deborah H Telman made no insider transaction in Gilead Sciences Inc (GILD). Other recent insider transactions involving Gilead Sciences Inc (GILD) include a net sale of 34,326 shares made by Merdad Parsey , a net sale of 15,000 shares made by Andrew D Dickinson , and a net sale of 22,671 shares made by Diane E. Wilfong .

In summary, during the past 3 months, insiders sold 12,230 shares of Gilead Sciences Inc (GILD) in total and bought 0 shares, with a net sale of 12,230 shares. During the past 18 months, 80,239 shares of Gilead Sciences Inc (GILD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,239 shares.

Gilead Sciences Inc (GILD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gilead Sciences Inc Insider Transactions

No Available Data

Deborah H Telman Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah H Telman. You might contact Deborah H Telman via mailing address: 2000 Galloping Hill Road, Kenilworth Nj 07033.

Discussions on Deborah H Telman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.